Related Experiment Video
Updated: Jun 26, 2026

Rapid Detection of Neurodevelopmental Phenotypes in Human Neural Precursor Cells (NPCs)
Published on: March 2, 2018
Normal FGF23 levels in adult idiopathic phosphate diabetes.
M Laroche1, J F Boyer, H Jahafar
1Service de Rhumatologie, CHU Rangueil, Toulouse, France. laroche.m@chu-toulouse.fr
Fibroblast growth factor 23 (FGF23) does not appear to cause idiopathic phosphate diabetes (IPD). However, FGF23 levels are lower in IPD patients with osteopenia or osteoporosis, suggesting a role in bone health.
Area of Science:
- Endocrinology
- Metabolic Bone Disease
- Mineral Metabolism
Background:
- Fibroblast growth factor 23 (FGF23) regulates phosphate metabolism and is implicated in phosphate diabetes.
- Idiopathic phosphate diabetes (IPD) can lead to osteoporosis and diffuse pain.
Purpose of the Study:
- To investigate the role of FGF23 in the pathogenesis of idiopathic phosphate diabetes (IPD).
Main Methods:
- Assessed FGF23, serum phosphate, 1-25(OH)2D3, and parathyroid hormone in 29 IPD patients and 15 controls.
- Measured bone mineral density (BMD) and evaluated phosphate reabsorption.
- Correlated FGF23 levels with phosphate and 1-25(OH)2D3 levels.
Main Results:
- IPD patients had lower serum phosphate than controls, but FGF23 levels were similar.
- FGF23 levels were significantly lower in IPD patients with osteopenia/osteoporosis compared to those with normal bone status.
- Serum phosphate levels were comparable between IPD patients with normal bone status and those with osteopenia/osteoporosis.
- Positive correlation between serum phosphate and FGF23; negative correlation between FGF23 and 1-25(OH)2D3.
Conclusions:
- FGF23 does not appear to be the primary cause of IPD.
- The FGF23/phosphate/1-25(OH)2D3 axis remains functional in IPD patients.
- Decreased FGF23 may be associated with bone loss in IPD.
Related Concept Videos
Roles of Electrolytes: Calcium and Phosphate
The calcium concentration in blood plasma is primarily regulated...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Diabetes: Symptoms, Diagnosis, and Complications
Serum Studies: Renal Function Tests
Hyperglycemia
Hypoglycemia and Glucagon